News AbbVie’s Skyrizi hits the spot in refractory psoriasis Antibody works when IL-17 inhibitors Like Novartis' Cosentyx and Lilly's Taltz fail.
News Sandoz bolsters biosimilars with $400m Slovenia plant New facility will be based at Sandoz' Lek subsidiary, and employ 300 staff when completed.
News FDA removes leash from Verzenio in early breast cancer Drug can now be used as adjuvant therapy without Ki-67 testing, taking a brake off prescribing.
News French court overturns €444m fine for Novartis, Roche Says companies did not abuse a market position to push Lucentis over off-label Avastin in AMD.
News Pharma responds to Türkiye/Syria earthquake With the death toll from the massive earthquake on the border of Türkiye
News Novartis drops Huntington's drug on phase 2b data Tucked away inside Novartis' fourth-quarter results update this morning is the news that the company has pulled the plug on a drug candidate for Huntington's disease after
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.